United Therapeutics Corporation, a public benefit corporation co-headquartered in Silver Spring, announced that in partnership with 3D Systems Corporation (NYSE: DDD) it has produced the world’s most complex 3D-printed object – a human lung scaffold – and demonstrated it at the LIFE ITSELF Conference that occurred May 31 to June 3, 2022 in San Diego. The event was organized and hosted by Dr. Sanjay Gupta and Marc Hodosh and was sponsored by CNN, United Therapeutics, and other prominent corporate leaders in healthcare.

Per the press release: Dr. Martine Rothblatt, United Therapeutics’ Chairperson and Chief Executive Officer and Chuck Hull, 3D Systems’ Co-Founder, Executive Vice President, and Chief Technology Officer for Regenerative Medicine, explained to conference attendees during a presentation entitled What’s the Future of Organ Transplantation? that these 3D-printable lung scaffold designs consisted of a record 44 trillion voxels that lay out 4,000 kilometers of pulmonary capillaries and 200 million alveoli. Scientists at United Therapeutics plan to cellularize these 3D-printed scaffolds with a patient’s own stem cells to create tolerable, transplantable human lungs that should not require immunosuppression to prevent rejection.


Montgomery County now represented for first time in Maryland VLT Program; MCEDC given an initial allocation of $1.5 million in state funding

Per The Montgomery County Economic Development Corporation (MCEDC): MCEDC was named last week as the ninth and newest fund manager in the Maryland Small, Minority and Women-Owned Business Program, also known as the Video Lottery Terminal (VLT) Program. There are currently eight VLT fund managers around Maryland that receive state funds to provide loans for small, minority and women-owned companies.


Company will use funds to continue rapid growth, expand network of 1,000+ practices, and add new wraparound services

Founded in 2014,  Bethesda-based Aledade is one of the leading physician enablement company helping independent practices, health centers, and clinics deliver better care to their patients and thrive in value-based care. On Monday, June 6th, Aledade announced it has closed a $123 million Series E funding round to support investments in value-based care for more seniors covered by Medicare Advantage (MA) and innovation that improves patient care and increases medical cost savings, including expanded offerings through its new health services subsidiary, Aledade Care Solutions (ACS). Returning investor OMERS Growth Equity led the round, which also included Fidelity Management & Research Company and other current investors.


Clearway Pain Solutions has opened its newest location in Bethesda. The office is located at 6410 Rockledge Dr #421 Bethesda, MD 20817 and is staffed by Dr. Anna Irwin. The Bethesda location joins the Germantown office as the only two Montgomery County locations.

Clearway Pain Solutions is a leading interventional pain management practice focused on relieving pain, restoring function, and renewing the quality of life for their patients. Clearway serves as a one-stop, comprehensive, integrated system of advanced pain solution treatments and as the end-to-end coordinator of interventional treatments, medication management, chiropractic services, physical therapy, massage therapy, and regenerative medicine, along with lab testing, durable medical equipment, and pharmacy services. The practice also specializes in helping patients recover from workplace and auto accident injuries.


Located at 4853 Cordell Avenue, the new space will be housed at the previous Unity Woods Yoga Studio, which stopped operating at the location in summer of 2020. Owned and operated by Maryland native Jen Dobbins, Unity Dance & Movement is the in-person outgrowth of a virtual dance space she’s operated since 2020.

“When COVID closed many area dance studios, several parents and students approached me, asking that I teach virtually,” Dobbins says. “I started offering instruction, via Zoom, in my living room. Word gradually got around and I eventually hired some of my former colleagues to keep up with demand. Now, as the region transitions beyond the pandemic, we have a unique opportunity to bring back in-person dance instruction to Bethesda.”


Earlier this month, QIAGEN N.V.  (which has its United States headquarters in Germantown) announced that it signed agreements to acquire a 96% majority ownership stake in BLIRT SA (Polish Stock Exchange: BLR), a manufacturer of recombinant enzymes for the life science industry based in Gdansk, Poland. 

Per the press release: BLIRT develops, manufactures and commercializes standardized and customized solutions for proteins and enzymes as well as molecular biology reagents. Its offering includes proteins and enzymes that are critical to the life sciences industry and diagnostic kit manufacturers, especially for non-COVID-19 applications. BLIRT, founded in 1994 in Gdansk, Poland, has approximately 90 employees and generated 2021 sales of less than $10 million.


Last month, Gaithersburg-based Adaptive Phage Therapeutics, Inc. (“APT”), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, announced that the AMR Action Fund has added $20 million to an existing $41 million Series B round as a co-investor, bringing the Series B total to $61 million. The new funding follows initial Series B closing in May 2021 and will be used to accelerate clinical trials against Prosthetic Joint Infection (PJI) and Diabetic Foot Osteomyelitis (DFO).

Per the press release: The round was initiated in May 2021 and led by Deerfield Management Company, with participation from a second institutional investor and Mayo Clinic. Proceeds of the AMR Action Fund’s investment are primarily intended to support APT’s clinical trials to address substantial unmet patient needs in Prosthetic Joint Infection (PJI) and Diabetic Foot Osteomyelitis (DFO).


Yount, Hyde and Barbour (YHB) is pleased to share, effective July 1, 2022, we will acquire Glass Jacobson, PA, a Maryland based tax, accounting, and management consulting firm.”

YHB recently announced the acquisition of Rockville-based accounting firm, Glass Jacobson. Glass Jacobson opened its first office 60 years ago, in 1962, and has been serving the area ever since. The move adds two additional offices (Rockville and Owings Mill) to the YHB portfolio. More below, courtesy of the press release:


Gaithersburg High School alumni, Dr. George Garbis and Viron  Wildy, have developed innovative new protection for athletes provides visual alert for overheating

ThermoPact will debut its groundbreaking MouthShield to the public at this year’s Pennsylvania Scholastic Football Coaches Association (PSFCA) Big 33 football weekend, where a team of Pennsylvania all-stars will go head-to-hea d with Maryland’s finest 33 high school players.


Silver Spring-based United Terapeutics has announced the First approval of a dry powder inhaler for treatment of PAH and PH-ILD. The DPI device represents a convenient option for administration of treprostinil therapy. Commercial launch activities underway; patient availability expected in June 2022. Per, BizJournals, this has “sent the local drugmaker’s stock soaring.”

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the U.S. Food and Drug Administration (FDA) has approved Tyvaso DPI™ (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) and pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve exercise ability. Tyvaso DPI represents a new formulation and inhalation device for inhaled treprostinil and is the only dry powder inhaler approved by the FDA for use in PAH and PH-ILD.


View More Stories